The significance of the hemochromatosis genetic variants in multiple myeloma in comparison to that of myelodysplastic syndrome

Annals of Hematology

Volumn 85, Issue 12, 2006, Pages 869-871

  Várkonyi, Judit ^a   Demeter, Judit ^a   Tordai, Attila ^b   Andrikovics, Hajnalka ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b NATIONAL MEDICAL CENTER   (Hungary)

Author keywords

HFE; Iron metabolism; MDS; Multiple myeloma; WBC

Indexed keywords

HFE PROTEIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION FUNCTION; GENE FREQUENCY; GENETIC REGULATION; GENETIC VARIABILITY; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HUMAN; INCIDENCE; IRON BLOOD LEVEL; IRON METABOLISM; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRANSFERRIN BLOOD LEVEL;

AGED; FEMALE; GENE FREQUENCY; GENETIC VARIATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; LEUKOCYTE COUNT; MALE; MEMBRANE PROTEINS; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROMES; VARIATION (GENETICS);

EID: 33750116894     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-006-0178-1     Document Type: Article

References (11)

1. Varkonyi J, Tarkovács G, Karádi I, Andrikovics H, Demeter J, Tordai A et al (2003) High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: The Budapest study on 50 patients. Acta Haematol 109:64-67
2. Dine G, Genty V, Rehn Y, Brahimi S (2003) Iron overload, MDS and HFE gene mutations: What relation? Leuk Res 27(Suppl 1)122a
3. Yaouang J, Grobois B, Jounaolle AM, Goasguen J, Leblay R (1997) Haemochromatosis Cys282Tyr mutation in pyridoxine-sensitive sideroblastic anaemia. Lancet 49:1475-1476
4. Melis MA, Cau M, Deidda F, Barella S, Cao A, Galanello R (2002) H63D mutations in the HFE gene increases iron overload in beta-thalassemia carriers. Haematologica 87(3):242-245
5. Feder JN, Gnirke A, Thomas W, Tsushiashi Z, Ruddy DA, Basava A et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408
6. Beckman LE, Van Landeghem GF, Sikstrom C, Wahlin A, Markevarn B, Hallmans G, Lenner P, Athlin L, Stenling R, Beckman L (1999) Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis 20:1231-1233
7. Varkonyi J, Tarkovacs G, Jakab L, Palicz T, Pánczél P, Németh K et al (1999) Myelodysplasia in autoimmune disorders, MGUS and multiple myeloma. Leuk Res 23(Suppl) 25a
8. Mori M, Abe T, Takei T, Shibata K (1992) The significance of myelodysplasia in untreated patients with multiple myeloma. Rhinochko-Kentsueki 33(5):662-665
9. Weh HJ, Seeger D, Junge I, Hossfeld DK (1996) Trisomy 8 preceding diagnosis of acute nonlymphocytic leukemia 2 years in a patient with multiple myeloma without cytological evidence of myelodysplasia. Ann Hematol 72(2):81-82
10. Nelson RL, Davis FG, Persky V, Becker E (1995) Risk of neoplastic and other diseases among people with heterozygozity for hereditary hemochromatosis. Cancer 76:875-879
11. Frachini M, Veneri D (2004) Iron overload and hematological malignancies. Hematol J 5:381-383